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Abstract
Background: In spite of limited evidence demonstrating a benefit, epidural analgesia (EA) is often
used for patients undergoing a pancreatectomy. In the present study, the impact of epidural analgesia
on post-operative outcomes after a pancreatectomy is examined.
Methods: Utilizing the Nationwide Inpatient Sample, the effect of EA on peri-operative outcomes after
a pancreatectomy was examined. Multivariable logistic and linear regression with propensity score
matching were utilized for risk adjustment.
Results: From 2008–2011, 12 440 patients underwent a pancreatectomy. Of these, 1130 (9.1%)
patients received epidural analgesia. Using univariate comparison, patients receiving EA had a signifi-
cantly decreased length of stay (LOS), hospital charges and post-operative inpatient mortality. In multi-
variate analyses, EA was independently associated with a decreased post-operative LOS (adjusted
mean difference = 1.19 days, P < 0.001), decreased hospital charges (adjusted mean difference =
$16 814, P = 0.002) and decreased post-operative inpatient mortality [adjusted odds ratio (OR) =
0.42, P < 0.001]. Using 1:1 propensity score matching, patients who received an EA (n = 1070) had
significantly decreased post-operative LOS (11.0 versus 12.1 days, P = 0.011), lower hospital charges
($112 086 versus $128 939, P = 0.001) and decreased post-operative inpatient mortality (1.5% versus
3.6%, P = 0.002) compared with matched controls without EA (n = 1070).
Conclusion: Analysis of a large hospital database reveals that EA is associated with improved peri-
operative outcomes after a pancreatectomy. Additional studies are required to understand fully if this
relationship is causal.
Received 27 October 2014; accepted 16 December 2014
Correspondence
Ryan C. Fields, Washington University in Saint Louis, 4990 Children’s Place, Suite 1160, Box 8109,
Saint Louis, MO 63110, USA. Tel: + 314 286 1694. Fax: + 314 222 6255. E-mail: fieldsr@wudosis.
wustl.edu
Background
Epidural Analgesia (EA) improves peri-operative outcomes in
patients undergoing select operations. For example, EA has
been associated with improved pain control as well as
decreased post-operative respiratory failure, decreased post-
operative pneumonia and quicker return of post-operative
bowel function compared with standard methods of pain con-
trol.1–6 A pancreatectomy is a morbid procedure with a high
rate of complications, which influence post-operative length of
stay (LOS), hospital cost and post-operative mortality. How-
ever, the role of EA in patients undergoing a pancreatectomy is
poorly defined. Thus, further investigation regarding the role
of EA in the care of patients undergoing a pancreatectomy is
warranted.
In spite of minimal evidence demonstrating the benefit after
a pancreatectomy, EA is frequently used. Many pancreatic
surgeons extrapolate data from studies using EA in other
abdominal operations, and routinely use EA in their patients.
With the growing use of enhanced recovery after surgery
(ERAS) programmes in pancreatectomy patients, many of
which incorporate EA, it is imperative to understand what role,
if any, EA should play in post-operative care.7,8 Thus, large
multi-institutional studies would be ideal to help determine
the impact of EA on post-operative outcomes in the pancrea-
tectomy population.
This study sought to examine the impact of EA on post-
operative outcomes after a pancreatectomy on a national level.
The Agency for Healthcare Research and Quality (AHRQ)
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Healthcare Cost and Utilization Project (HCUP) Nationwide
Inpatient Sample (NIS) for 2008 to 2011 was utilized to deter-
mine whether EA had an effect on post-operative outcomes in
patients undergoing a pancreatectomy. The hypothesis was that
patients, who receive EA, have decreased post-operative LOS,
decreased hospital charges and decreased post-operative inpa-
tient mortality after risk-adjustment for patient, operative and
hospital factors.
Patients and methods
Study design and patient population
This was a retrospective cohort study using the AHRQ HCUP
NIS for 2008 to 2011 to identify patients age 18 years or older
undergoing a pancreaticoduodenectomy [International Classifi-
cation of Diseases, Ninth Revision, Clinical Modification
(ICD9-CM) procedure codes: 52.51 and 52.7], total pancrea-
tectomy (ICD9-CM procedure code: 52.6) and distal pancrea-
tectomy (ICD9-CM procedure codes: 52.52). Twenty-seven
patient admissions were deleted because these were duplicate
records. The NIS is the largest publicly available all-payer inpa-
tient health care database in the United States, containing data
from more than 7 million hospital stays each year.
Study variables
Common post-operative complications using ICD9-CM diag-
nosis codes in pancreatectomy patients have been identified in
a similar AHRQ HCUP database.9 Patients who received EA
were identified by ICD-9-CM procedure codes 03.90 and
03.91, as has been done previously using the NIS.10 The AHRQ
comorbidity software, Version 3.7, was used to identify comor-
bidities present at admission by utilizing measures defined by
Elixhauser et al. based on ICD9-CM diagnosis codes.11 The
other race category included Asians, Pacific Islanders, Native
Americans and Hispanics. Hospital pancreatectomy volume
quartiles were defined using the total number of pancreatecto-
mies performed at individual hospitals between 2008 and 2011.
The American Hospital Association (AHA) Annual Survey of
the Hospitals file was used to determine hospital bed size and
teaching status. AHA hospital size is based on the number of
hospital beds, specific to the hospital’s location and teaching
status. Cells with fewer than 11 patients per variable were rela-
belled as ‘<11’ in compliance with the HCUP data use agree-
ment.
Statistical analysis
Chi-square and Student’s t tests were used for univariate com-
parisons. Multivariable logistic and linear regression were used
to examine the association of EA with LOS, hospital charges
and inpatient mortality as appropriate. Propensity scores were
estimated using a non-parsimonius multivariable logistic
regression model including age, gender, race, comorbidities
(congestive heart failure, chronic lung disease, diabetes, chronic
renal failure, obesity, weight loss, alcohol abuse and drug
abuse), insurance status, pancreatectomy type, cancer status,
hospital pancreatectomy volume, hospital teaching status, and
AHA hospital size with epidural analgesia as the dependent
variable.12 Patients who received EA were then matched 1:1 to
patients who did not receive EA using a greedy matching
algorithm with a caliper width of 0.2 standard deviations of
the logit of the propensity score.13 Covariate balance between
matched pairs was assessed using the standardized difference,
with values less than 10% indicating minimal imbalance.14 All
P-values were two-sided and values <0.05 were considered sta-
tistically significant in all analyses. All statistics were performed
using SAS version 9.3 (SAS Inc. Cary, NC, USA).
Results
From 2009 through to 2011, 12 440 patients underwent a pan-
createctomy in the NIS. The mean age was 61.9 years (stan-
dard deviation: 13.8 years) and 51.0% were women. Patient,
operative and hospital statistics are summarized in Table 1.
Unadjusted outcomes by EA status after a pancreatectomy
are shown in Table 2. After adjusting for age, gender, race,
comorbidities, insurance status, pancreatectomy type, cancer
status, hospital pancreatectomy volume, hospital teaching
status and AHA hospital size (Table 3), EA was independently
associated with decreased post-operative LOS, decreased hospi-
tal charges and decreased inpatient mortality.
A 1:1 propensity score matching was performed using vari-
ables shown in Table 4. In all, 1070 matched pairs were
obtained for the comparison, a match rate of 94.7% for all
patients with epidurals (Table 4). The groups were well bal-
anced with standardized differences of less than 10% for all
variables. Patients, who received EA, had significantly
improved outcomes compared with propensity score-matched
controls without EA (Table 5).
Discussion
Previous studies examining the role of EA in pancreatectomy
patients have failed to show a benefit. In a study of patients
undergoing a pancreaticoduodenectomy, Pratt et al.15 found
that patients, who received EA, had lower pain scores, but also
had increased rates of major complications. In a study includ-
ing gastrectomy and pancreatectomy patients, Shah et al.16
found that EA did not significantly improve pain control nor
was it associated with significantly different rates of post-oper-
ative complications, such as pneumonia and ileus, or death. It
is likely that the efficacy of epidural catheters is dependent on
multiple factors. For example, the skill level and experience of
the anaesthesiologist, the use of narcotics versus local anesthet-
ics and how catheters are managed intra- and post-operatively
all likely play a major role in whether EA is effective.17 Thus,
there may be tremendous institutional bias in a single institu-
tion studies regarding the efficacy of EA. A population-level
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Table 1 Characteristics of pancreatectomy patients with and without an epidural analgesia
Characteristic Mean (SD) or No. (Column %) P-value
No Epidural (n = 11 310) Epidural (n = 1130)
Age, years
Mean (SD) 62.0 (13.9) 61.6 (13.7) 0.410
Gender
Male 5530 (48.9%) 562 (49.7%) 0.033
Female 5770 (51.0%) 564 (49.9%)
Missinga <11 <11
Race
White 7657 (67.7%) 706 (62.5%) <0.001
Black 972 (8.6%) 65 (5.8%)
Other 2681 (23.7%) 359 (31.8%)
Comorbidities
CHF 368 (3.3%) 28 (2.5%) 0.157
Chronic Lung Disease 1463 (12.9%) 154 (13.6%) 0.509
Diabetes 3220 (28.5%) 323 (28.6%) 0.936
Chronic renal failure 426 (3.8%) 40 (3.5%) 0.702
Obesity 954 (8.4%) 80 (7.1%) 0.116
Weight loss 1665 (14.7%) 192 (17.0%) 0.041
Alcohol abuse 417 (3.7%) 37 (3.3%) 0.481
Drug abuse 133 (1.2%) 19 (1.7%) 0.140
Insurance
Private 4647 (41.1%) 477 (42.2%) 0.046
Medicaid 780 (6.9%) 61 (5.4%)
Self-Pay 350 (3.1%) 36 (3.2%)
Medicare 5158 (45.6%) 503 (44.5%)
Missing 375 (3.3%) 53 (4.7%)
Pancreatectomy type
Whipple 7403 (65.5%) 838 (74.2%) <0.001
Total 589 (5.2%) 51 (4.5%)
Distal 3318 (29.3%) 241 (21.3%)
Diagnosis
Malignant 7402 (65.5%) 775 (68.6%) 0.034
Benign 3908 (34.6%) 355 (31.4%)
Hospital pancreatectomy volume quartile
1st (<22 patients) 2894 (25.6%) 219 (19.4%) <0.001
2nd (22–69 patients) 2837 (25.1%) 309 (27.4%)
3rd (70–139 patients) 2869 (25.4%) 219 (19.4%)
4th (>139 patients) 2710 (24.0%) 383 (33.9%)
Hospital teaching status
Teaching 1819 (16.1%) 173 (15.3%) 0.499
Non-teaching 9491 (83.9%) 957 (84.7%)
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approach was used in an attempt to overcome this limitation,
and avoid drawing conclusions based on the EA practices of a
single institution.
Previous randomized trials have unequivocally demonstrated
a benefit of epidural analgesia over standard intravenous
narcotics in patients undergoing abdominal operations about
pain relief.2 In addition, previous randomized studies and
meta-analyses have demonstrated that EA is associated with
decreased rates of certain complications, such as pulmonary
morbidity and ileus, as well as decreased mortality.5,6 Similarly,
in the propensity score, matched analysis, patients who
received EA had decreased rates of respiratory failure/pneumo-
nia and death after a pancreatectomy. In addition, patients
who received EA also had decreased rates of acute renal failure,
an association that has also been reported with EA in other
types of operations.4,18
In multivariate analyses, pancreatectomies performed at hos-
pitals in the lowest volume quartile were associated with
increased LOS, increased hospital charges and increased inpa-
tient mortality. Previous studies have found an association
between lower pancreatectomy volume hospitals and worse
peri-operative outcomes,19,20 and this study confirms this find-
ing. While EA use was more common at hospitals in the high-
est pancreatectomy volume quartile, the association of hospital
pancreatectomy volume with improved post-operative out-
comes was independent of epidural use. This suggests that the
effect of increased volume on improved outcomes is not medi-
ated solely by the use of EA.
A major strength of this study was the ability to examine
the impact of EA at the population level. Potential institutional
confounders, such as hospital size, pancreatectomy volume and
teaching status were accounted for in risk-adjustment, and a
large number of patients were included, which provided the
power to detect a difference in mortality. In addition to tradi-
tional multivariate regression methods, propensity score
matching was used as a separate analysis to examine the
impact of EA on post-operative outcomes. Because the deci-
sion for a patient to receive EA is largely dependent on
surgeon preferences and institutional practices, it is not appro-
priate to directly compare patients who received EA to those
Table 1 Continued
Characteristic Mean (SD) or No. (Column %) P-value
No Epidural (n = 11 310) Epidural (n = 1130)
AHA hospital sizeb
Small 600 (5.3%) 56 (5.0%) 0.030
Medium 1506 (13.3%) 149 (13.2%)
Large 9081 (80.3%) 923 (81.7%)
Missinga 123 (1.1%) <11
aCells with fewer than 11 patients per variable were relabeled as ‘ <11’ in compliance with the HCUP data use agreement.
bAHA hospital size is based on the number of hospital beds, specific to the hospital’s location and teaching status.
Table 2 Unadjusted post-operative outcomes of pancreatectomy patients with and without an epidural analgesia
Outcome Mean (SD) or No. (Column %) P value
No epidural (n = 11 310) Epidural (n = 1130)
Postoperative length of stay, days 12.0 (10.5%) 10.9 (8.7) <0.001
Total hospital charges, $ 128 804 (137 377) 112 962 (109 347) <0.001
Inpatient mortality 391 (3.5%) 17 (1.5%) <0.001
Any complication 4902 (43.3%) 493 (43.6%) 0.853
Myocardial infarction 105 (0.9%) 12 (1.1%) 0.657
Hypotension/Shock 254 (2.3%) 14 (1.2%) 0.026
Pneumonia/Respiratory failure 1138 (10.1%) 73 (6.5%) <0.001
Gastroparesis/nausea & vomiting 974 (8.6%) 110 (9.7%) 0.202
Total parenteral nutrition 1421 (12.6%) 118 (10.4%) 0.039
Acute renal failure 608 (5.4%) 38 (3.4%) 0.004
Any infection 2681 (23.7%) 253 (22.4%) 0.321
Urinary tract infection 784 (6.9%) 89 (7.9%) 0.236
Surgical site infection 1216 (10.8%) 136 (12.0%) 0.186
Blood transfusions 3042 (26.9%) 261 (23.1%) 0.006
DVT/PE 280 (2.5%) 32 (2.8%) 0.465
HPB 2015, 17, 551–558 ª 2015 International Hepato-Pancreato-Biliary Association
554 HPB
Table 3 Multivariate analyses of factors associated with post-operative outcomes after a pancreatectomy (n = 12 440)
Variable Length of stay, days Hospital charges, $ Inpatient mortality
Mean difference (95% CI) P value Mean difference (95% CI) P-value OR (95% CI) P-value
Age, per year 0.01 (0.00 to 0.03) 0.143 70 (158 to 297) 0.548 1.04 (1.02 to 1.05) <0.001
Sex
Male reference Reference reference
Femalea 0.91 (1.29 to 0.55) <0.001 14 347 (18 980 to 9 714) <0.001 0.81 (0.66 to 0.99) 0.040
Race
White reference Reference reference
Black 0.45 (0.21 to 1.10) 0.179 1 249 (7 308 to 9 806) 0.775 0.92 (0.61 to 1.38) 0.682
Other 0.33 (0.15 to 0.81) 0.175 5 697 (197 to 11 196) 0.042 1.25 (0.99 to 1.58) 0.063
Comorbidities
CHFa 3.78 (2.76 to 4.82) <0.001 48 704 (35 529 to 61 879) <0.001 2.20 (1.54 to 3.16) <0.001
Chronic lung disease 0.21 (0.75 to 0.33) 0.443 2 801 (9 622 to 4 019) 0.421 1.05 (0.79 to 1.39) 0.743
Diabetes 0.54 (0.43 to 1.52) 0.275 5 931 (6 844 to 18 706) 0.363 1.01 (0.63 to 1.63) 0.953
Chronic renal failurea 1.35 (0.38 to 2.32) 0.007 30 201 (17 675 to 42 727) <0.001 2.03 (1.41 to 2.95) <0.001
Obesity 0.00 (0.65 to 0.65) 1.000 449 (8 844 to 7 945) 0.916 1.17 (0.81 to 1.69) 0.406
Weight lossa 6.19 (5.67 to 6.72) <0.001 74 466 (65 981 to 78 951) <0.001 1.89 (1.51 to 2.37) <0.001
Alcohol abuse 0.37 (0.62 to 1.36) 0.466 13 124 (668 to 25 581) 0.039 1.38 (0.82 to 2.34) 0.226
Drug abuse 1.02 (0.67 to 2.71) 0.239 4 049 (17 189 to 25 287) 0.709 1.24 (0.48 to 3.20) 0.651
Insurance
Private reference reference reference
Medicaida 2.13 (1.37 to 2.89) <0.001 28 229 (18 721 to 37 738) <0.001 1.68 (1.08 to 2.62) 0.023
Self-Pay 0.74 (0.32 to 1.80) 0.542 1 790 (11 610 to 15 190) 0.794 1.52 (0.82 to 2.83) 0.188
Medicare 0.80 (0.33 to 1.28) 0.001 9 626 (3 613 to 15 639) 0.002 1.24 (0.94 to 1.65) 0.136
Pancreatectomy type
Distal reference reference reference
Whipplea 4.51 (4.27 to 5.15) <0.001 47 771 (42 236 to 53 306) <0.001 2.69 (1.94 to 3.72) <0.001
Totala 5.03 (4.14 to 5.92) <0.001 55 770 (44 739 to 66 801) <0.001 2.82 (1.65 to 4.83) <0.001
Diagnosis
Benign reference reference reference
Malignant 0.28 (0.70 to 0.15) 0.207 5 871 (459 to 11 282) 0.034 1.21 (0.93 to 1.58) 0.161
Hospital pancreatectomy volume quartile
1st (<22 patients)a 2.59 (1.95 to 3.23) <0.001 36 747 (28 802 to 44 691) <0.001 2.27 (1.61 to 3.19) <0.001
2nd (22–69 patients) 1.53 (1.00 to 2.07) <0.001 1 319 (5 397 to 8 036) 0.700 1.51 (1.10 to 2.07) 0.011
3rd (70–139 patients) 0.05 (0.48 to 0.58) 0.849 29 815 (23 295 to 36 335) <0.001 0.92 (0.65 to 1.30) 0.632
4th (>139 patients) reference reference reference
Hospital teaching status
Teaching 0.74 (0.17 to 1.31) 0.011 14 947 (7 608 to 22 287) <0.001 0.99 (0.75 to 1.31) 0.927
Non-teaching reference reference reference
AHA hospital sizeb
Small 0.27 (0.68 to 1.21) 0.583 24 050 (34 885 to 13 215) <0.001 0.82 (0.51 to 1.29) 0.381
Medium 0.01 (0.57 to 0.54) 0.964 1 999 (9 338 to 5 340) 0.593 0.86 (0.64 to 1.16) 0.321
Large reference reference reference
Epidurala 1.19 (1.86 to 0.53) <0.001 16 814 (24 716 to 8 912) 0.002 0.42 (0.26 to 0.69) <0.001
aDenotes variables significantly associated with all three postoperative outcome measures.
bAHA hospital size is based on the number of hospital beds, specific to the hospital’s location and teaching status.
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Table 4 Propensity score matched comparison of patients with and without epidurals
Characteristic Mean (SD) or No. (Column %) Standardized differencea
No epidural (n = 1070) Epidural (n = 1070)
Age, years
Mean (SD) 63.0 (13.2) 62.3 (13.2) 4.8%
Sex
Male 531 (49.6%) 537 (50.2%) 1.1%
Female 539 (50.4%) 533 (49.8%)
Race
White 669 (62.5%) 678 (63.4%) 3.2%
Black 57 (5.3%) 62 (5.8%)
Other 344 (32.2%) 330 (30.8%)
Comorbidities
CHF 27 (2.5%) 27 (2.5%) <1.0%
Chronic lung disease 143 (13.4%) 147 (13.7%) 1.1%
Diabetes 327 (30.6%) 306 (28.6%) 4.3%
Chronic renal failure 29 (2.7%) 39 (3.6%) 5.3%
Obesity 69 (6.5%) 74 (6.9%) 1.9%
Weight loss 166 (15.5%) 171 (16.0%) 1.3%
Alcohol abuse 26 (2.4%) 33 (3.1%) 4.0%
Drug abuse 14 (1.3%) 17 (1.6%) 2.4%
Insurance
Private 474 (44.3%) 475 (44.4%) 4.4%
Medicaid 55 (5.1%) 61 (5.7%)
Self-Pay 29 (2.7%) 35 (3.3%)
Medicare 512 (47.9%) 499 (46.6%)
Pancreatectomy type
Whipple 808 (75.5%) 804 (75.1%) 3.2%
Total 38 (3.6%) 33 (3.1%)
Distal 224 (20.9%) 233 (21.8%)
Diagnosis
Malignant 782 (73.1%) 751 (70.2%) 6.4%
Benign 288 (26.9%) 319 (29.8%)
Hospital pancreatectomy volume quartile
1st (<22 patients) 223 (20.8%) 211 (19.7%) 3.6%
2nd (22–69 patients) 292 (27.3%) 295 (27.6%)
3rd (70–139 patients) 220 (20.6%) 215 (20.1%)
4th (>139 patients) 335 (31.3%) 349 (32.6%)
Hospital teaching status
Teaching 884 (82.6%) 902 (84.3%) 4.5%
Non-teaching 186 (17.4%) 168 (15.7%)
AHA hospital sizeb
Small 49 (4.6%) 56 (5.2%) 3.8%
Medium 136 (12.7%) 143 (13.4%)
Large 885 (82.7%) 871 (81.4%)
aStandardized Difference <10% indicates minimal covariate imbalance between propensity matched cohorts (Austin et al. Stat Med. 2009)
bAHA hospital size is based on the number of hospital beds, specific to the hospital’s location and teaching status.
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who did not. By matching patients with similar probabilities of
receiving EA, analogous to randomization, propensity score
matching attempts to adjust for this selection bias as well as
more evenly distribute any residual confounders not accounted
for in the analysis.
As with any study utilizing administrative data, there are
limitations to this work. The data used in this study were at
the population level; thus, individual patient records could not
be examined, which prevented us from being able to know the
precise details surrounding hospital stays. For example, neither
the duration of EA use nor the adequacy of EA with regards to
pain control could be examined. Because the NIS was used,
this study relied on ICD-9CM codes to identify EA. Thus, it is
not known whether patients, who had unsuccessful attempts at
EA or had non-functional EA, were included in the EA group.
Similarly, where patients were managed post-operatively (ICU
versus surgical ward) as well as the types of medications used
in EA (i.e. narcotics versus local anaesthetics versus both) are
also not included in the NIS. It would also have been beneficial
to know how intravenous fluids were managed both intra- and
post-operatively as EA has been associated with vasodilatory
hypotension, which could result in overzealous fluid adminis-
tration. As the NIS is limited to inpatient data, it only includes
outcomes that occurred during patients’ initial post-operative
stay, and could not account for any complications diagnosed
in the outpatient setting or upon readmission. Additionally,
some important factors, such as baseline functional status, are
not included in the NIS, so there is also the possibility of
residual confounding, which could result in incomplete risk
adjustment. The involvement of a specialized pain team, which
often participates in the post-operative care of patients with
EA, is not tracked in the NIS. Therefore, there is a possibility
that EA is simply a surrogate for the involvement of a special-
ized pain team in post-operative management. While propen-
sity score matching is a valid method for analysing
non-randomized observational data, it is by no mean perfect.
A large prospective randomized trial of EA versus no EA in
pancreatectomy patients would be the best method to deter-
mine if EA improves outcomes.
In conclusion, within a large, administrative hospital data-
base, EA is associated with improved peri-operative outcomes
and reduced hospital charges after a pancreatectomy. The find-
ing that EA improves peri-operative outcomes after a pancrea-
tectomy must be interpreted with caution. This analysis, at the
national level, may not absolutely apply to any one individual
hospital. Additional studies are required to fully understand if
this relationship is causal as well as to determine how to best
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